Filgrastim Injection IP

Name: Filgrastim Injection IP
Brand: NEETCO BIOPHARMA
Price: 249 INR
Availability: InStock

Price 249 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Filgrastim Injection IP Specification

Indication
Neutropenia, to promote neutrophil production in patients undergoing chemotherapy, bone marrow transplant, or HIV infection.

Dosage Form
Injection

Salt Composition
Filgrastim

Enzyme Types
Growth Factor (Colony-Stimulating Factor)

Feature
Sterile, Pyrogen-free, Single-use vials, Effective and safe for neutropenia treatment

Ingredients
Filgrastim, Acetate buffer, Polysorbate 80, Sodium, Water for injection

Application
Parenteral use in hospitals and clinics for increasing white blood cell count

Ph Level
Approximately 4.0

Temperature Needed For Fermentation
Not applicable (Manufactured via recombinant DNA technology in E. coli)

Physical Color/Texture
Clear, colorless solution

Enzymatic Activity
Stimulates proliferation and differentiation of neutrophil precursors

Storage Instructions
Store between 2C 8C; protect from light, do not freeze

Shelf Life
24 months

Strength
300 mcg / 1ml

Container Material
Glass vials

Preservatives
No preservatives

Regulatory Approval
IP (Indian Pharmacopoeia) Standards

Compatibility
Compatible with standard saline solution

Route of Administration
Subcutaneous or intravenous

Brand Name
Filgrastim Injection IP

Packaging Size
1ml vial

About Filgrastim Injection IP

Experience the sizzling benefit of Filgrastim Injection IP, a top-rated and bargain option for elevating white blood cell counts in patients facing neutropenia. This top-notch, preservative-free formula comes in enviable 1ml glass vials, each containing a clear, sterile, pyrogen-free 300 mcg/ml dose. With exceptional compatibility with standard saline and meeting IP (Indian Pharmacopoeia) standards, this growth factor injection is administered subcutaneously or intravenously. Trusted by hospitals and clinics, Filgrastim Injection IP supports unsurpassed outcomes for those undergoing chemotherapy, bone marrow transplant, or HIV treatments. Safe storage between 2C-8C for a 24-month shelf life.

Key Advantages and Application Areas

Filgrastim Injection IP offers an exceptional advantage by rapidly promoting neutrophil production, crucial for patients at risk of infection due to chemotherapy, bone marrow transplant, or HIV infection. Its usage is strictly parenteral, administered either subcutaneously or intravenously by healthcare professionals. Commonly found in top medical centers and clinics, this product ensures optimal results in supporting the immune system, making it indispensable where patient safety is the priority.

Domestic Market, Sample Policy, and Certifications

Filgrastim Injection IP enjoys outstanding acceptance in the main domestic markets across India, attracting doctors and hospital buyers alike with its attractive sale price. Certified to meet IP standards, it guarantees quality with each arrival. Distributors and traders can expect swift charge on sample dispatch, ensuring efficient order processes. Backed by regulatory approval and a transparent sample policy, this product remains a trusted choice for healthcare professionals nationwide.

FAQ's of Filgrastim Injection IP:

Q: How does Filgrastim Injection IP help patients?

A: Filgrastim Injection IP stimulates the proliferation and differentiation of neutrophil precursors, significantly increasing white blood cell counts and helping patients combat infections during chemotherapy, bone marrow transplant, or HIV infection.

Q: What is the recommended method of administration for Filgrastim Injection IP?

A: The recommended administration route for Filgrastim Injection IP is subcutaneous or intravenous injection, and it should be given only by qualified healthcare professionals in clinical or hospital settings.

Q: When should Filgrastim Injection IP be used?

A: Filgrastim Injection IP is used when patients are diagnosed with neutropenia, especially if it results from cancer treatments like chemotherapy, bone marrow transplantation, or HIV infection therapies.

Q: Where can Filgrastim Injection IP be applied?

A: This injection is best applied in hospitals and clinics, where parenteral administration and patient monitoring are carried out by medical experts to ensure safety and efficacy.

Q: What is the process for ordering and receiving samples of Filgrastim Injection IP?

A: Distributors and hospitals can request product samples, which are dispatched with minimal charge. Prompt arrival and simple sample policies streamline evaluation before purchase.

Q: What are the main benefits of using Filgrastim Injection IP over other options?

A: Filgrastim Injection IP stands out due to its IP certification, top-notch safety profile, sterile single-use glass vials, and compatibility with standard saline solution, ensuring effective and trustworthy treatment for neutropenia.

Tell us about your requirement